Identification of the prognostic immune subtype in copy-number high endometrial cancer.
Mingyi MaoFang JiangRuiqin HanYang XiangPublished in: Journal of gynecologic oncology (2023)
Our study revealed heterogeneous immune subtypes in CNH EC and identified GZMM as a prognostic biomarker. The stratified classification strategy combining molecular and immune subtypes provides valuable insights for future clinical practice.